Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
abbreviation
|
| gptkbp:alternativeName |
gptkb:the_pill
|
| gptkbp:canBe |
emergency contraception (in some regimens)
|
| gptkbp:contains |
estrogen
progestin |
| gptkbp:contraindication |
gptkb:cancer
gptkb:liver_disease history of thromboembolic disorders |
| gptkbp:effect |
about 91% with typical use
over 99% with perfect use |
| https://www.w3.org/2000/01/rdf-schema#label |
OCPs
|
| gptkbp:introducedIn |
1960
|
| gptkbp:manufacturer |
various pharmaceutical companies
|
| gptkbp:mayIncreaseRiskOf |
breast cancer (slightly)
|
| gptkbp:notProtectAgainst |
sexually transmitted infections
|
| gptkbp:prescriptionRequired |
true
|
| gptkbp:reduces |
gptkb:cancer
gptkb:endometrial_cancer |
| gptkbp:regimen |
21 days active, 7 days placebo
28 days continuous |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache increased risk of blood clots |
| gptkbp:standsFor |
oral contraceptive pills
|
| gptkbp:usedFor |
birth control
treatment of acne regulation of menstrual cycles |
| gptkbp:bfsParent |
gptkb:OCP_uniform
|
| gptkbp:bfsLayer |
6
|